Krystal Biotech has formed a cup with handle with a buy point of 206.97, according to the daily and weekly charts on IBD MarketSurge. This is a second-stage base for the biotech stock that could lead to higher gains. Krystal Biotech uses viral vectors to deliver genetic material to different cells to treat conditions such as cystic fibrosis and certain lung diseases.